Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms contributing to these benefits remain largely undetermined, despite offering the potential to reveal new targets for therapeutic intervention. Substantial changes in circulating total bile acids are known to occur after VSG. Moreover, bile acids are known to regulate metabolism by binding to the nuclear receptor FXR (farsenoid-X receptor, also known as NR1H4). We therefore examined the results of VSG surgery applied to mice with diet-induced obesity and targeted genetic disruption of FXR. Here we demonstrate that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach. Rather, VSG is associated with increased circulating bile acids, and associated changes to gut microbial communities. Moreover, in the absence of FXR, the ability of VSG to reduce body weight and improve glucose tolerance is substantially reduced. These results point to bile acids and FXR signalling as an important molecular underpinning for the beneficial effects of this weight-loss surgery.
Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms contributing to these benefits remain largely undetermined, despite offering the potential to reveal new targets for therapeutic intervention. Substantial changes in circulating total bile acids are known to occur after VSG. Moreover, bile acids are known to regulate metabolism by binding to the nuclear receptor FXR (farsenoid-X receptor, also known as NR1H4). We therefore examined the results of VSG surgery applied to mice with diet-induced obesity and targeted genetic disruption of FXR. Here we demonstrate that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach. Rather, VSG is associated with increased circulating bile acids, and associated changes to gut microbial communities. Moreover, in the absence of FXR, the ability of VSG to reduce body weight and improve glucose tolerance is substantially reduced. These results point to bile acids and FXR signalling as an important molecular underpinning for the beneficial effects of this weight-loss surgery.
Perhaps surprisingly, the most effective and durable therapies for the treatment of obesity involve surgical, rather than pharmacological or behavioural, intervention. In contrast to the modest impact of diet and exercise, most individuals that lose weight with bariatric surgery maintain reduced levels of body fat for many years 1 . This is associated with considerable improvements in co-morbidities. Notably, 40% of obese type-2 diabetes mellitus patients that undergo bariatric surgery achieve full remission within one year 2 . Despite its efficacy, however, surgery is not an attractive therapeutic option for many individuals suffering from obesity and its consequences. Therefore it is both scientifically and clinically imperative that we identify molecular mechanisms responsible for weight loss and other metabolic improvements so we can target affected pathways in a less-invasive manner.
In the bariatric procedure VSG, approximately 80% of the stomach is removed along the greater curvature. This creates a gastric 'sleeve' in continuity with the oesophagus and duodenum. VSG induces loss of body weight and fat mass, and improves glucose tolerance in humans and in rodents 2, 3 . Importantly, the efficacy of VSG is comparable to the more complex Roux-en-Y gastric bypass (RYGB), which not only creates a smaller stomach but also involves surgical re-routeing of the small intestine 4, 5 . A recent randomized controlled trial found that VSG and RYGB produced nearly the same remission of type-2 diabetes mellitus after one year, and that both procedures were significantly superior to medical management 2 .
Conventional wisdom holds that bariatric surgeries, including VSG and RYGB, lead to weight loss and resolution of type-2 diabetes mellitus directly as a result of reducing the ability of the stomach to physically accommodate a meal. That is, the stomach is made smaller, perhaps imposing a mechanical restriction on the amount of food that can be consumed at one time. Moreover, in RYGB, the flow of nutrients and biliopancreatic secretions is re-routed, perhaps limiting macronutrient absorption. However, growing evidence indicates that restriction and malabsorption are not the primary mechanisms driving metabolic improvements after bariatric surgery 6 . As just one example, a substantial proportion of diabetic patients are able to stop taking their medications within days of surgery, before substantial weight loss has occurred 2 . Given the short time frame, some controversy exists about the mechanisms underlying this dramatic outcome. Some hypothesize that acute improvements are independent of weight loss and result from changes in gut physiology, including altered neurohumoral signalling or altered microbial ecology. In contrast, others suggest these benefits are the result of the hypocaloric post-operative milieu and rapid weight loss 7, 8 .
Among the changes to gut physiology that occur following bariatric surgery is altered enterohepatic circulation of bile acids. Both RYGB and VSG are associated with a significant increase in circulating total bile acids in humans and in rodent models 9, 10 . It is now clear that, in addition to aiding the mechanical digestion and absorption of lipids, bile acids also bind to FXR to function as signalling molecules contributing to the regulation of various metabolic processes. In light of this role, we hypothesized that FXR-signalling links altered bile acid homeostasis to important post-operative changes in metabolism and gut microbial communities, thereby contributing to the maintenance of weight loss and improvements in glucose control observed following VSG. To test this hypothesis, we applied VSG surgery to diet-induced obese mice with targeted genetic disruption of FXR and their wild-type littermates.
Unbiased pathway analysis
We used sequencing of messenger RNA (mRNA-seq), together with subsequent unbiased pathway analysis, to identify key biological pathways that were altered in the distal small intestine following VSG ( Fig. 1 ). Consistent with our recent report that VSG significantly alters the expression of hepatic genes involved in lipid and bile acid metabolism 9 , the pathway 'Nuclear receptors in lipid metabolism and toxicity' emerged as one of the top pathways enriched in genes differentially regulated (fold change $1.5) in VSG (P 5 7.18 3 10 25 ). Intriguingly, among the other top pathways, several point towards an altered gut microbiota. Specifically, the glutathione pathway (P 5 6.00 3 10 28 ), which plays important roles in nutrient metabolism and antioxidant defence, is known to be significantly altered by the presence/absence of a microbiota-and this is associated with changes in bile acid composition 11, 12 . Likewise, many of the biotransformations (P 5 4.81 3 10 25 ) that are increased probably reflect an altered microbiota, induced for detoxification of metabolites such as secondary bile acids. Finally, changes in gut microbial communities have been extensively linked to altered host immune response including interferon-signalling 13, 14 (P 5 1.25 3 10 24 ).
FXR, VSG and body composition
Because we and others have consistently observed increased circulating total bile acids 9, 10, 15, 16 and increased FXR signalling 9,17 following various bariatric procedures including VSG, and because Fxr was one of the regulated genes identified in our pathway analysis, we hypothesized that FXR-signalling contributes to the metabolic benefits of VSG. To test this, we first generated whole-body FXR knockout mice (KO), and their wild-type littermate controls (WT; Methods). Because KO mice are somewhat resistant to diet-induced obesity 18 , we maintained these mice on a 60% high-fat diet (HFD) for 10 weeks before surgery, such that both WT and KO mice became obese. Both genotypes carried more than 30% of their body weight as fat before surgery ( Fig. 2a, b) ; our previous data indicate that this level of adiposity provides more-thansufficient opportunity for VSG-induced body weight and fat loss 3, 19 .
VSG or sham surgery was performed in these obese male WT and KO mice. In the first week after surgery, WT and KO mice lose a comparable amount of weight relative to their sham-operated controls. However, whereas WT-VSG mice maintained this relative weight loss for the duration of the experiment (Fig. 2c , repeated measures analysis of variance (RM ANOVA) with Tukey post-hoc tests, P , 0.001), the KO-VSG animals recovered it. Within 5 weeks, the body weight of KO-VSG animals was no longer different from that of sham-operated controls ( Fig. 2d , RM ANOVA with Tukey post hoc, P , 0.001). Moreover, when we measured body composition at 11 weeks after the operation, WT-VSG mice had half the body fat of sham-operated WT controls, while the body fat of KO-VSG and KO-sham operated mice was equivalent ( Fig. 2e , f , two-way ANOVA with Tukey post hoc, P , 0.01).
We note that KO-sham mice continue to gain weight at a slower rate than WT-sham mice following surgery; this needs to be taken into consideration. However, the failure of FXR-VSG mice to sustain body weight and body fat loss is unlikely to be a product of KO mice being relatively resistant to diet-induced obesity, for two reasons. First, we have observed potent reductions in body fat after VSG in mice that have as little as an average 7 g of body fat 3, 19 , whereas the FXR-KO mice in this study had an average of 9 g. Second, we executed post-hoc analyses, selecting the heaviest KO and the lightest WT mice to create a subset with comparable body weights and composition before the surgery. Importantly, in this subset WT-VSG mice maintain an 11.3 g decrement in body weight and a 10. -Log 10 (P-value for pathway enrichment)
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Type II interferon signalling (N = 6) Gbp1, Cxcl10, Reg1, Nox2, Socs3, Irf4 RESEARCH ARTICLE significantly heavier than WT-VSG mice by 8 weeks after surgery (Extended Data Fig. 1a -c, two-way ANOVA with Tukey post hoc, P , 0.001) and maintain a greater fat mass than WT-VSG mice at 11 weeks after surgery (Extended Data Fig. 1d , e, two-way ANOVA with Tukey post hoc, P , 0.05).
FXR, VSG and feeding behaviour
To understand how KO-VSG animals were able to recover this body weight, we measured weekly HFD intake in these singly housed mice. Both WT and KO mice consumed fewer calories during the first week following VSG as compared to sham surgery. However, whereas WT-VSG mice maintained this lower food intake for up to 3 weeks ( Fig. 3a , RM ANOVA with Tukey post hoc, P , 0.001), KO-VSG mice were only hypophagic during the first week ( Fig. 3c , RM ANOVA with Tukey post hoc, P , 0.001). Importantly, and in contrast to what occurs when animals are calorically-restricted in the absence of surgery 20 , this caloric deficit was not recovered at later time points in WT-VSG mice, allowing for the maintenance of reduced body weight and body fat over the course of the study (Fig. 3a, b ). On the other hand, beginning in postoperation week 4, KO-VSG mice actually consumed more food than sham operated controls ( Fig. 3c, d , Tukey post hoc P , 0.05), suggesting that FXR signalling is necessary for the repression of rebound hyperphagia following caloric restriction initially achieved by VSG. This result is also consistent with our growing understanding that VSG is a metabolic, rather than purely restrictive, procedure 6 , as both genotypes are left with a similarly small stomach after VSG. Eight weeks after surgery, WT-VSG mice had consumed 15% fewer calories than WT-sham mice, but cumulative food intake by KO-VSG mice was equivalent to sham-operated controls (Fig. 3e , two-way ANOVA with Tukey post hoc, P , 0.01). Further, when we allowed the mice to choose among three pure macronutrient diets, WT-VSG mice had a significantly reduced preference for fat compared to WT-sham. Unexpectedly, KO-sham mice already exhibit a substantial reduction in the preference for fat compared to WT-sham. This was not further reduced by VSG ( Fig. 3f , g, two-way ANOVA with Tukey post hoc, P , 0.05). However, we cannot exclude the possibility that the lack of an effect in the KO mice represents a physiological 'floor' that cannot be further reduced by VSG.
FXR, VSG and glucose tolerance
To investigate whether FXR-signalling contributes to improvements in glucose tolerance observed following VSG, we challenged fasted mice with an intraperitoneal (i.p.) injection of dextrose at a dose of 1 g per kg?body weight. VSG was associated with a 20% decrease in fasting blood glucose in WT mice, whereas it was associated with a 24% increase in fasting blood glucose in KO mice (Fig. 4a , two-way ANOVA with Tukey post hoc, P , 0.001). WT-VSG mice exhibited a substantial improvement in the ability to clear the i.p. injection of glucose, reflected as a 35% reduction in the area under the curve (AUC) relative to sham-operated controls. In contrast, KO-VSG and sham-operated mice exhibited no differences in glucose tolerance (Fig. 4b, c , two-way ANOVA with Tukey post hoc, P , 0.01; t-test, P , 0.001). Although the present findings do not address the question of whether the improvements observed in WT-VSG relative to WT-sham mice are independent of weight loss, we note that KO-VSG and WT-VSG mice had equivalent body weights at the time of this glucose tolerance test. Despite this, when the glucose excursions of WT-VSG and KO-VSG mice are compared directly, KO-VSG mice exhibit significantly impaired glucose clearance at both 30 and 60 min (two-way RM ANOVA with Tukey post hoc, P , 0.05, Extended Data Fig. 2 ).
FXR, VSG and gut microbial communities
Gut microbial communities are altered in obese individuals 21 and respond to changes in caloric intake and macronutrient content of the diet 22 . Recent evidence implicates changes in gut microbial communities, both in humans and mice, as potential contributors to the benefits of weightloss surgery [23] [24] [25] [26] . Transplantation of the gut microbiota from obese mice into germ-free mice is associated with weight gain 27, 28 , whereas transplantation of gut microbiota from RYGB mice is associated with reduced weight gain compared to transplantation with sham microbiota 26 .
Because bariatric surgery affects the prevalence of many microbial species, it has been difficult to ascertain which specific changes might functionally contribute to its benefits. The present study provides an opportunity to address this question, by comparing the interacting effects of FXR deficiency and VSG on gut microbial ecology. Specifically, because FXR KO mice are refractory to the metabolic benefits of VSG, we infer that any changes in gut microbial communities that occur after VSG irrespective of genotype are not sufficient (but may nonetheless be necessary) to recapitulate its benefits. On the other hand, changes that result from an interaction between genotype and surgery are more likely to be critical to the potent effect of VSG. Pertinent to this, bile acids can modulate the abundance and composition of gut microbes, both directly, and indirectly by activation of FXR-signalling 29, 30 . Conversely, the gut microbiota can modify bile acid composition by microbial enzymatic activities, thereby altering both bile acid homeostasis and FXR signalling 31, 32 .
Mice were killed 14 weeks following surgery, and we extracted genomic DNA from caecal contents and performed pyrosequencing of the VSG. a, b, WT mice eat significantly less during the first 3 weeks after VSG versus sham surgery; this is not recovered at later time points. c, d, KO mice eat significantly less during the first week after VSG versus sham surgery; beginning at week 4, KO-VSG mice compensate for this initial caloric deficit by consuming more calories than shamoperated controls. e, By 8 weeks after surgery, cumulative food intake by WT-VSG mice was 15% less than WT-sham mice, whereas food intake by KO-VSG and sham-operated mice was equivalent. f, When given the choice among three pure macronutrient diets, WT-VSG mice exhibit a blunted preference for dietary fat relative to carbohydrates (Carb.) and protein (Pro.). g, Among WT mice, VSG reduces the preference for dietary fat. Moreover, loss of FXR is associated with lack of preference for dietary fat that is not further altered by the surgery. Data are shown as mean 6 s.e. *P , 0.05, **P , 0.01, ***P , 0.001. For panels a-e, n 5 13 WT-sham, 10 WT-VSG, 9 KO-sham, 10 KO-VSG. For panels f, g, n 5 12 WT-sham, 6 WT-VSG, 8 KO-sham, 7 KO-VSG.
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16S ribosomal RNA gene. Because all the mice in this study were maintained on the same purified HFD, and because the average caloric intake by WT-VSG mice was only reduced in the first 3 weeks of this 14-week study (Fig. 3) , any observed differences are unlikely to be secondary to differing caloric intake or macronutrient content of the diet. Moreover, because WT-VSG, KO-sham and KO-VSG mice had equivalent body weights at death, any observed differences among these groups are unlikely to be secondary to differing body weight or composition.
Weighted UniFrac analysis (sensitive to abundances of taxa) 33 showed separation of WT-VSG samples from WT-sham samples along the first principal component, indicating that VSG had a stronger effect on microbiota composition in WT mice than in KO mice (Fig. 5a , Extended Data Fig. 3 , two-way ANOVA with Tukey post hoc). As shown in Fig. 5b , c, the separation of samples in the principal components analysis plot reflects differences in the Bacteroidetes and Firmicutes levels. In light of these differences, we further identified specific taxonomic changes that result from an interaction between genotype and surgery, as these may represent microbial groups that are critical to the potent effects of bariatric surgery-though future studies involving colonization of germ-free mice would be required for definitive evidence supporting a functional involvement.
The relative abundance of several bacteria previously identified as important modulators of systemic metabolism was altered differently by VSG according to genotype. Specifically, the relative abundance of Bacteroides was substantially reduced in WT-VSG mice relative to WTsham controls, but did not vary with surgery among KO mice (Fig. 5d , two-way ANOVA with Tukey post hoc, P , 0.05). A recent study investigating the therapeutic potential of probiotic treatment in obese women found that decreasing prevalence of Bacteroides was associated with decreasing adiposity and improved glucose control 34 . Likewise, in the present study, decreasing abundance of Bacteroides was associated with decreased weight gain, fat gain (Extended Data Fig. 4 ), and decreased AUC in a glucose tolerance test-suggesting a functional association that depends on FXR.
An uncharacterized genus in the Porphyromonadaceae family, a bacterial group negatively correlated with type-1 diabetes 35 , and decreased in HFD-fed mice 22 , was substantially increased in WT-VSG mice relative to WT-sham controls. In contrast, this group was reduced in KO-VSG mice relative to their sham-operated controls (Fig. 5e , two-way ANOVA with Tukey post hoc, P , 0.05).
Finally, the relative abundance of Roseburia was 12-fold higher in WT-VSG caeca compared to WT-sham, but the abundance of this microbe in both KO groups resembled the WT-sham group (Fig. 5f , two-way ANOVA with Tukey post hoc, P , 0.05). Importantly, and consistent with our findings, two recent gut metagenome analyses identified decreased abundance of Roseburia as highly discriminant for type-2 diabetes mellitus, in both a European and a Chinese population 36, 37 .
Likewise, a study investigating the therapeutic effect of a prebiotic treatment in rodents found that increased abundance of Roseburia was associated with weight loss and improved glucose tolerance, independent of food intake 38 . In the present study, the abundance of Roseburia was negatively correlated with AUC in the glucose tolerance test (Extended Data Fig. 4 ), and this was due primarily to the relationship within the WT-VSG group (R 2 5 0.75, P , 0.05, Fig. 5g ), suggesting an FXR-dependent functional association.
In addition, we observed genotype-independent changes in the relative abundance of the genera Lactobacillus and Lactococcus and of Enterobacteriaceae (Extended Data Fig. 5 ). Consistent with this, an increase in Escherichia coli and other enterobacteria has likewise been reported after RYGB 23, 24, 26 . Such changes may indeed contribute to the benefits of VSG and other bariatric procedures, but the present data suggest they are not sufficient to elicit improvements in energy balance and glucose homeostasis.
Changes in gut microbiota may influence host metabolism in part due to the ability of the microbiota to attain colonic dietary conversion, resulting mostly in the production of fatty acid end products. Pertinent to this, a wide range of data now links the production of short-chain fatty acids (SCFAs) to various metabolic outcomes 36, 37, 39, 40 . To this end, we measured caecal SCFAs and other organic acids produced by the gut microbiota. There were no differences in the total abundance of SCFAs among the four groups (Extended Data Table 1 ). The relative abundances of butyrate and propionate (Extended Data Fig. 6a, b ), but not acetate (Extended Data Fig. 6c ) were altered by VSG and this did not differ between genotypes (two-way ANOVA with Tukey post hoc, P , 0.05). The resulting decrease in the acetate:butyrate ratio (Extended Data Fig. 6d , two-way ANOVA with Tukey post hoc, P , 0.001) possibly indicates that acetate is more efficiently converted to butyrate following VSG. Consistent with the increase in Lactobacillus and Lactococcus, we also observed an increase in lactate following VSG (Extended Data  Table 1 ). Again, although such changes may indeed contribute to the benefits of VSG and other bariatric procedures, the present data suggest they are not sufficient to elicit metabolic improvements.
Discussion
Though a number of local physiological and environmental variables may be altered by VSG, here we have identified a critical role for altered bile acid signalling. Taken together, the present results demonstrate that a functional FXR pathway is necessary for sustained weight loss, suppression of rebound hyperphagia and improved glucose control following VSG. Importantly, KO mice have an equivalently small stomach, yet they do not demonstrate the same improvements as WT mice. Thus our findings directly contradict the common assumption that mechanical restriction, resulting from the reduced stomach size, is sufficient to mediate the therapeutic effects of VSG. 
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In agreement with this, FXR-signalling is implicated in the regulation of lipid and glucose metabolism [41] [42] [43] [44] . Initial reports emphasized a protective role, concluding that FXR signalling is necessary for normal glucose homeostasis. FXR KO mice exhibit impaired glucose and insulin tolerance when maintained on a chow diet 41, 42 , despite modestly elevated plasma bile acids. In apparent contrast, however, they are resistant to HFD-induced obesity and glucose intolerance 18 . Intriguingly, two studies investigating the effect of the synthetic FXR agonist GW4064 on the development of HFD-induced obesity and glucose intolerance 45, 46 yielded opposite results. Whereas Watanabe et al. 46 report greater sensitivity to diet-induced metabolic dysfunction, Ma et al. 45 report resistance to diet-induced obesity following treatment with GW4064. A major difference between the two studies was route of administration. Watanabe et al. delivered the drug orally via the diet, whereas Ma et al. delivered it intraperitoneally. FXR is expressed in multiple organs important for the regulation of metabolism, including liver, adipose tissue and intestine, and its activation in these compartments may elicit opposing effects on metabolism, perhaps contributing to this discrepancy. Relevant to this, bile acids may also affect metabolism by signalling via the G-protein-coupled receptor TGR5, raising the possibility of cross-talk between these systems 47 . Finally, we note these contradictory phenotypes have likewise been observed in the complex regulation of gene expression by other members of the nuclear receptor family. The PPARc haploinsufficient mouse, for example, is more insulin sensitive despite the fact that PPARc agonists are well-known for their insulin-sensitizing effects 48 . Like PPARc, FXR and other nuclear receptors may either activate or repress the transcription of target genes, depending on the presence of co-activator and co-repressor complexes. Therefore, loss-of-FXR function might paradoxically be associated with a relative increased expression in a subset of FXR-regulated genes, while still making the animal resistant to treatments that activate FXR. This may explain the present conundrum that FXR KO mice are simultaneously resistant to some of the deleterious metabolic effects of consuming a HFD and also relatively unresponsive to the metabolic benefits of VSG.
Bariatric surgical procedures, such as VSG, are currently the most effective therapy for the treatment of obesity and are moreover associated with substantial improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms contributing to these benefits remain largely undetermined, despite offering tremendous potential to reveal new targets for therapeutic intervention. Progress towards this goal has probably been hindered by a widespread belief that surgery exerts its effects simply by making it physically difficult to consume or absorb calories. The current work provides an alternative framework-that is, it identifies FXR-signalling as a molecular mechanism necessary for both key changes to gut microbial communities and many associated metabolic benefits of VSG. These findings provide a new understanding of the mechanisms that underlie the benefits of bariatric surgery and suggest new targets for developing less-invasive therapeutic interventions.
METHODS SUMMARY
RNA-seq and unbiased pathway analysis. These were performed using RNA collected from the distal small intestine of VSG and sham-operated, pair-fed male (SPF) mice that were the subjects of a previously published study 9 . Animals. Singly-housed FXR KO mice and their WT littermates 49 were allowed ad libitum access to a high-fat diet (HFD) and water unless otherwise noted. VSG or sham surgery was performed as described elsewhere 3 . Microbiota. Caecal microbiota composition was analysed by pyrosequencing of the V1-V2 region from the bacterial 16S rRNA gene. PCR amplicons were generated from caecal DNA. Sequence data were analysed by using the QIIME software package (version 1.5.0) 50 . of Bacteroidetes and Firmicutes respectively. d, Relative abundance of Bacteroides was reduced in WT-VSG compared to WT-sham operated mice, but did not differ in KO mice. e, Relative abundance of one genus in the Porphyromonadaceae family was increased in WT-VSG compared to WT-sham operated mice, but was reduced in KO-VSG mice relative to KO-sham operated controls. f, Relative abundance of Roseburia was increased in WT-VSG compared to WT-sham operated mice, but did not differ in KO mice; individual data points show outliers. g, Among WT-VSG mice, the relative abundance of Roseburia was tightly correlated with fasting blood glucose. Data are presented as Tukey box-plots. *P , 0.05, **P , 0.01, ***P , 0.001. n 5 12 WT-sham, 7 WT-VSG, 9 KO-sham, 8 KO-VSG.
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Statistical analyses. Data are presented as mean 6 standard errors or as Tukey box-plots, as noted. Data were analysed using the appropriate ANOVA or repeated measures ANOVA (RM ANOVA), followed by Tukey's post-hoc tests, or by t-test as indicated. The data were tested for normality and homogeneity of variance. In cases where the data failed these assumptions, the analyses were also done after rank transformation. In no cases did this alter the statistical significance or interpretation of the findings, so the statistics reported in the figures are from the nontransformed analyses. Data were analysed using Prism (Graph Pad, San Diego CA) or Sigma Stat (SYSTAT, San Jose CA) software with the critical value, a, set at P , 0.05.
